Location: Home
  • search
  • go
  • Relate News
  • 10/19/2023Drug R&D and Product Registration News Digest 10/2023 (3)
  • 10/19/2023Recent Executive Moves
  • 10/18/2023MOF Drafts New Policy to Improve Internal Control of Public Hospitals
  • 10/18/2023JPO Officially Announces Initiation and Info Submission Arrangements o...
  • 10/18/2023CDE Issues the Technical Guidelines for Pharmaceutical Research of New...
  • 10/17/2023Elevar and Hengrui Announce Global License Deal for PD-1 Inhibitor Cam...
  • 10/17/2023Novo Nordisk in $1.3B Deal to Buy KBP's Hypertension Drug Ocedurenone
  • 10/17/2023China's BMI System Saw Its Income Up 9.3% in the First Eight Months 
  • 10/17/2023China: The New Frontier for Western CDMOs? (Contract Pharma)
  • 10/16/2023CDE Solicits Comments on the Issues and Solutions for Slow Virus Vecto...
  • 10/16/2023NMPA and the Chinese Customs Issue Announcement over Designation of Th...
  • 10/15/2023The SparX Group Enters into a Collaboration with Arovella Therapeutics...
  • 10/15/2023EpimAb and Almirall Announce Bispecific Antibody License Agreement
  • 10/15/2023Pfizer CEO Albert Bourla Wants To Tap 'Chinese Science' As The Drug Co...
  • 10/15/2023The Rising Importance of Patient Advocacy Innovations in Asia (PharmEx...
  • 10/13/2023NMPA Issues the Announcement for Generic Research of Drug Products wit...
  • 10/13/2023CDE Issues Two Technical Docs for Generic Research of Drug Products wi...
  • 10/13/2023CDE Issues the Work Standards for Submission and Review of Drug Clinic...
  • 10/13/2023SAMR Issues the Provisions for Quality Control of Drug Distribution an...
  • 10/13/2023NMPA Issues the Announcement on Matters Relating to API Re-registratio...
  • 10/13/2023Drug R&D and Product Registration News Digest 10/2023 (2)
  • 10/12/2023MediLink, BioNTech Ink Strategic Collaboration and Worldwide License ...
  • 10/12/2023NMPA and NHC Issues No.1 Supplement of ChP (2020)
  • 10/12/2023Review of Chinese Biopharma Industry Performance in September 2023
  • 10/12/2023China Approves Trial Use of Eisai/Biogen's Alzheimer Drug in Hainan's ...
  • 10/12/2023China's Birthrate Plummets to Record Low Despite Government Efforts
  • 10/12/2023China's Vast Opportunities In Health Care Attract Global Telemedicine ...
  • 10/11/2023JIXING and Wuzhou Enter Distribution Agreement for Macau
  • 10/11/2023Gritgen Therapeutics Launches Commercial GMP Facility in China
  • 10/10/2023NHSA Announces Conclusion of Expert Evaluation for 2023 DRDL Inclusion...
  • Page:30/718 Total number of articles:21536: [First][<<] [28] [29] [30] [31] [32] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group